Fluvastatin is a member of the statin drug class, used to treat hypercholesterolemia and to prevent cardiovascular disease.

The global Fluvastatin Sodium Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fluvastatin Sodium Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fluvastatin Sodium Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fluvastatin Sodium Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fluvastatin Sodium Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Mylan
Teva Pharm
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablets
Capsules

Segment by Application
Adult
Children